Treatment spent the most R&D expenses, ‘tumor treatment’

Published: 2016-03-24 16:29:00
Updated: 2016-03-24 10:04:06

A treatment spent the most R&D expenses by pharmaceutical companies was known to be tumor treatments.

The Korea Health Industry Development Institute recently unveiled the information through the ‘2014 Pharmaceutical Product/Medical Device R&D Status’ report.  

According to the R&D expenses cat...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.